New medical guidelines back use of Novartis heart failure drug

LONDON, May 20 (Reuters) - New global guidelines on the

treatment of heart failure endorse the use of Novartis'

Entresto, boosting the prospects for a drug that has struggled

to gain traction since its launch last year.

Read more